Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

QLT Inc (NASDAQ:QLTI)

2.46
Delayed Data
As of Feb 12
 +0.09 / +3.80%
Today’s Change
2.32
Today|||52-Week Range
4.40
-7.52%
Year-to-Date
No recent news for QLT Inc.

Today’s Trading

Previous close2.37
Today’s open2.39
Day’s range2.37 - 2.46
Volume24,644
Average volume (3 months)228,713
Market cap$125.2M
Dividend yield159.25%
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+83.67%
Earnings growth (this year)-468.75%
Earnings growth (next 5 years)+74.60%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.78

Competitors

 Today’s
change
Today’s
% change
AVXLAnavex Life Sciences...+0.15+4.14%
PRTOProteon Therapeutics...+0.24+3.31%
NVIVInVivo Therapeutics ...+0.29+7.63%
RKDAArcadia Biosciences ...+0.15+6.47%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateFebruary 18, 2016
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$0.00
Annual profit (last year)-$4.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Independent Director
Geoffrey F. Cox
Chief Financial Officer &
Vice President-Finance
Glen W. Ibbott
Corporate headquarters
Vancouver, British Columbia

Forecasts

Partner Offers